TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Blueray Therapeutics (Shanghai)
US Patent
Blueray Therapeutics (Shanghai)
US Patent
Affinity DataIC50: <100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair